Lorenzo Maso
Principal Scientist Aethon Therapeutics
Lorenzo Maso is an inventor of the proprietary HapImmune™ platform exclusively licensed to Aethon Therapeutics. His expertise is the discovery and affinity maturation of antibodies, for which he combines protein engineering and structural biology techniques, such as yeast display and cryo-EM.
Seminars
Wednesday 20th May 2026
Expanding Therapeutic Possibilities Pursuing pMHC Targets Beyond Convention
11:00 am
- Antigen-guided TCE development
- Targeting haptenated peptides as a way of breaking HLA restriction
- Exploiting resistance mechanisms to cancer treatments that unlock new targets for immunotherapies
New Data
